Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China flag China · Delayed Price · Currency is CNY
29.52
0.00 (0.00%)
Apr 30, 2025, 3:00 PM CST

SHA:600329 Revenue

Tianjin Pharmaceutical Da Ren Tang Group Corporation had revenue of 1.46B CNY in the quarter ending March 31, 2025, a decrease of -26.59%. This brings the company's revenue in the last twelve months to 6.68B, down -18.12% year-over-year. In the year 2024, Tianjin Pharmaceutical Da Ren Tang Group Corporation had annual revenue of 7.31B, down -11.14%.

Revenue (ttm)
6.68B
Revenue Growth
-18.12%
P/S Ratio
3.00
Revenue / Employee
1.45M
Employees
4,619
Market Cap
20.00B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20247.31B-915.58M-11.14%
Dec 31, 20238.22B-26.94M-0.33%
Dec 31, 20228.25B1.34B19.42%
Dec 31, 20216.91B303.89M4.60%
Dec 31, 20206.60B-390.23M-5.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition